The PROMPT Pilot Study
- Conditions
- Tobacco DependenceTobacco Use DisorderTobacco Use Cessation
- Interventions
- Behavioral: Smoking Cessation Counselling
- Registration Number
- NCT03626064
- Lead Sponsor
- Ottawa Hospital Research Institute
- Brief Summary
The PROMPT Pilot Study is a feasibility mixed methods prospective cohort study following principles of community-based participatory action research. The study recruited 80 people who use drugs and followed them for 6 months while providing access to counselling, nicotine replacement therapy and peer-support in a community setting. A notable reduction in average cigarette use per day (20.5 to 9.3) and illicit substance use (18.8%) was observed at study-end. PROMPT's patient engagement model is an effective harm-reduction strategy for the growing opioid use crisis and can improve the health outcomes of marginalised at-risk populations worldwide.
- Detailed Description
Objective To determine the feasibility of a Community-Based Participatory Tobacco Dependence Strategy (PROMPT) in the inner city population of Ottawa (Canada).
Design A feasibility mixed methods prospective cohort study following principles of community-based participatory action research.
Intervention Recruited 80 people who use drugs, followed them for 6 months while providing access to counseling, nicotine replacement therapy and peer-support in a community setting.
Setting Community research office in downtown Ottawa, adjacent to low-income housing, shelter services and street-based drug consumption.
Primary outcome Retention rate at 6-month follow-up.
Secondary outcome Biochemically validated 7-day point prevalence smoking abstinence at 26 weeks, self-reported abstinence in the past 7 days with exhaled carbon monoxide ≤10 ppm.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- currently living in Ottawa for at least 3 months prior to enrolment
- 16 years or older
- have used drugs in the past year (excluding marijuana and alcohol)
- have smoked tobacco in the past 7 days
- consent declined (refusal from participant or decision maker)
- any person accessing addictions treatment (in-patient drug rehabilitation) and hence unavailable for follow-up
- any person currently or recently (in the past 30 days) enrolled in a smoking cessation program
- anyone with a terminal illness with a life expectancy of <3 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description PROMPT Participants Smoking Cessation Counselling 80 participants who are homeless or at-risk for homelessness, smoke tobacco, and identify as People Who Use Drugs in Ottawa. PROMPT Participants Nicotine Replacement Therapy 80 participants who are homeless or at-risk for homelessness, smoke tobacco, and identify as People Who Use Drugs in Ottawa.
- Primary Outcome Measures
Name Time Method Retention of Study Participants 6 months Retention rate at 6-month follow-up
- Secondary Outcome Measures
Name Time Method Biochemical Validation of Smoking Cessation Outcome 6 months Biochemically validated 7-day point prevalence smoking abstinence at 26 weeks, self-reported abstinence in the past 7 days with exhaled carbon monoxide ≤10 ppm.